312 related articles for article (PubMed ID: 9088999)
1. Oral doxophylline in patients with chronic obstructive pulmonary disease.
Villani F; De Maria P; Ronchi E; Galimberti M
Int J Clin Pharmacol Ther; 1997 Mar; 35(3):107-11. PubMed ID: 9088999
[TBL] [Abstract][Full Text] [Related]
2. [The influence of serum theophylline concentration on the bronchodilating effect of salbutamol inhalation for bronchial asthma].
Tsukioka K; Nakamata M; Kondo A; Hashimoto T
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jul; 28(7):950-5. PubMed ID: 1977948
[TBL] [Abstract][Full Text] [Related]
3. [Influence of the combination of theophylline and beta 2 agonists by oral route on pulmonary function of patients with chronic obstructive lung disease].
Carvalho-Pinto RM; Terra Filho M; Cukier A; Santos SR; Verrastro C; Teixeira LR; Vargas FS
Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(4):166-9. PubMed ID: 1843713
[TBL] [Abstract][Full Text] [Related]
4. [A comparison of bronchodilating drugs in the treatment of stable COPD].
Nishimura K; Koyama H; Izumi T
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):835-43. PubMed ID: 1385837
[TBL] [Abstract][Full Text] [Related]
5. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
Majumdar S; Sen S; Mandal SK
J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
[TBL] [Abstract][Full Text] [Related]
6. Effect of theophylline in chronic obstructive lung disease.
Umut S; Gemicioğlu B; Yildirim N; Barlas A; Ozüner Z
Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):149-52. PubMed ID: 1592541
[TBL] [Abstract][Full Text] [Related]
7. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.
Murali PM; Rajasekaran S; Paramesh P; Krishnarajasekar OR; Vasudevan S; Nalini K; Lakshmisubramanian S; Deivanayagam CN
Respir Med; 2006 Jan; 100(1):39-45. PubMed ID: 15905081
[TBL] [Abstract][Full Text] [Related]
8. [Effects of adrenergic beta 2 agonists by oral route on theophylline blood levels].
Terra Filho M; Santos SR; Cukier A; Verrastro C; Carvalho-Pinto RM; Fiss E; Vargas FS
Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(4):170-2. PubMed ID: 1843714
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma -- a double-blind randomized placebo-controlled multicentre clinical trial.
Goldstein MF; Chervinsky P
Med Sci Monit; 2002 Apr; 8(4):CR297-304. PubMed ID: 11951074
[TBL] [Abstract][Full Text] [Related]
10. Treatment of reversible chronic airways obstruction with doxofylline compared with slow-release theophylline: a double-blind, randomized, multicentre trial.
Melillo G; Balzano G; Jodice F; De Felice A; Campisi V; Capone M; Di Filippo A; Foddai G; Franzone JS; Grossi E
Int J Clin Pharmacol Res; 1989; 9(6):397-405. PubMed ID: 2699466
[TBL] [Abstract][Full Text] [Related]
11. Which patients benefit from adding theophylline to beta 2-agonist treatment in severe acute asthma?
Janson C; Boman G; Boe J
Ann Allergy; 1992 Aug; 69(2):107-10. PubMed ID: 1354948
[TBL] [Abstract][Full Text] [Related]
12. Clinical comparison of albuterol, isoetharine, and metaproterenol given by aerosol inhalation.
Berezuk GP; Schondelmeyer SW; Seidenfeld JJ; Jones WN; Bootman JL
Clin Pharm; 1983; 2(2):129-34. PubMed ID: 6349905
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the bronchodilator effects of broxaterol and salbutamol.
Casali L; Rossi A; Manazza P; Colombo ML; Zoia MC
Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):93-7. PubMed ID: 2900816
[TBL] [Abstract][Full Text] [Related]
14. Treatment of moderate chronic obstructive pulmonary disease (stable) with doxofylline compared with slow release theophylline--a multicentre trial.
Santra CK
J Indian Med Assoc; 2008 Dec; 106(12):791-2, 794. PubMed ID: 19370950
[TBL] [Abstract][Full Text] [Related]
15. [Effects of salbutamol and ipratropium bromide on arterial blood gases in patients with stable COPD].
Ozdemir T; Geçkin E; Oğüş C; Cilli A
Tuberk Toraks; 2003; 51(2):132-7. PubMed ID: 15143418
[TBL] [Abstract][Full Text] [Related]
16. [Heart rhythm changes in patients with chronic obstructive bronchopneumopathies: effects of different methylxanthine drugs].
Cipri A; Pozzar F; Dini FL
Minerva Cardioangiol; 1992; 40(1-2):31-9. PubMed ID: 1630668
[TBL] [Abstract][Full Text] [Related]
17. [Response of airflow to the administration of bronchodilator agents in patients with chronic obstructive lung disease or asthma].
Barbas CS; Barbas Filho JV; do Amaral e Silva E; Stávale ML; Amato Mde P
Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(4):163-5. PubMed ID: 1843712
[TBL] [Abstract][Full Text] [Related]
18. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Aug; 443():1-321. PubMed ID: 12595920
[TBL] [Abstract][Full Text] [Related]
20. [Response to inhaled bronchodilators in chronic airway obstruction].
Holten K
Tidsskr Nor Laegeforen; 1993 Feb; 113(4):444-7. PubMed ID: 8465284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
